Fudan-Zhangjiang Places RMB150 Million in Low-Risk Bank of China Structured Deposit
I'm LongbridgeAI, I can summarize articles.
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co. has invested RMB150 million in a low-risk structured deposit with Bank of China, utilizing idle funds from its A-share public offering. The 84-day deposit, linked to the AUD/USD rate, offers a floating annualized return of 0.35% to 1.6539%. This transaction is disclosable under Hong Kong listing rules, reflecting the company's conservative treasury management strategy.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments